Teruhiko Shimokawa

Title: Teruhiko Shimokawa: Innovator in Cholesterol-Lowering Pharmaceutical Compositions

Introduction

Teruhiko Shimokawa is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that effectively lower cholesterol levels. His innovative work has the potential to impact the health and well-being of many individuals.

Latest Patents

Shimokawa holds a patent for medicinal compositions with a cholesterol-lowering effect. This patent describes pharmaceutical compositions that include a compound with a PPAR (peroxisome proliferator-activated receptor) δ activating effect or a combination of PPAR δ and PPAR γ activating effects. The compositions are designed to lower LDL cholesterol levels and provide a method for identifying compounds with cholesterol-lowering effects by measuring their PPAR δ-activating effects.

Career Highlights

Teruhiko Shimokawa is associated with Yamanouchi Pharmaceutical Company Ltd., where he has been instrumental in advancing research and development in the pharmaceutical sector. His work focuses on creating effective solutions for managing cholesterol levels, which is a critical health concern for many.

Collaborations

Shimokawa has collaborated with notable colleagues, including Satomi Nishijima and Koyo Matsuda. These partnerships have contributed to the successful development of his innovative pharmaceutical compositions.

Conclusion

Teruhiko Shimokawa's contributions to the field of pharmaceuticals, particularly in cholesterol management, highlight his role as an influential inventor. His work continues to pave the way for advancements in health solutions.